These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16446183)

  • 1. Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery.
    Colwell CW; Kwong LM; Turpie AG; Davidson BL
    J Arthroplasty; 2006 Jan; 21(1):36-45. PubMed ID: 16446183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy, and safety.
    Kwong LM; Muntz JE
    Am J Orthop (Belle Mead NJ); 2002 Nov; 31(11 Suppl):16-20. PubMed ID: 12463579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
    Turpie AG
    Surg Technol Int; 2004; 13():261-7. PubMed ID: 15744699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.
    Agnelli G; Bergqvist D; Cohen AT; Gallus AS; Gent M;
    Br J Surg; 2005 Oct; 92(10):1212-20. PubMed ID: 16175516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.
    Mismetti P; Samama CM; Rosencher N; Vielpeau C; Nguyen P; Deygas B; Presles E; Laporte S;
    Thromb Haemost; 2012 Jun; 107(6):1151-60. PubMed ID: 22476471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
    Lu JP; Knudson MM; Bir N; Kallet R; Atkinson K
    J Am Coll Surg; 2009 Nov; 209(5):589-94. PubMed ID: 19854398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients.
    Fuji T; Fujita S; Ochi T
    Int Orthop; 2008 Aug; 32(4):443-51. PubMed ID: 17468868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
    Tian H; Song F; Zhang K; Liu Y
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients.
    Turpie AG; Lensing AW; Fuji T; Boyle DA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):114-21. PubMed ID: 19339838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT Study.
    Singelyn FJ; Verheyen CC; Piovella F; Van Aken HK; Rosencher N;
    Anesth Analg; 2007 Dec; 105(6):1540-7, table of contents. PubMed ID: 18042845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry.
    Warwick D; Friedman RJ; Agnelli G; Gil-Garay E; Johnson K; FitzGerald G; Turibio FM
    J Bone Joint Surg Br; 2007 Jun; 89(6):799-807. PubMed ID: 17613508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design of venous thromboembolism prophylaxis trials: is enoxaparin more effective than fondaparinux?
    Lalourcey L
    Int J Clin Pract; 2003 May; 57(4):289-94. PubMed ID: 12800460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
    Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
    Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of wound healing after total knee arthroplasty in a randomized prospective trial comparing fondaparinux with enoxaparin.
    Bonneux IM; Bellemans J; Fabry G
    Knee; 2006 Mar; 13(2):118-21. PubMed ID: 16387501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement.
    Eriksson BI; Borris LC; Dahl OE; Haas S; Huisman MV; Kakkar AK; Misselwitz F; Muehlhofer E; Kälebo P
    Thromb Res; 2007; 120(5):685-93. PubMed ID: 17292948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study.
    Silvestri F; Pasca S; Labombarda A; Barbi A; Desideri M; Guidi P; Rogato A; Zaramella M; Bergamo M; Ageno W; Barillari G
    Minerva Med; 2014 Jun; 105(3):221-8. PubMed ID: 24988087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.